CMDh RECOMMENDATION ON IMPLEMENTATION OF ARTICLE 30 DECISIONS cf. DIRECTIVE[removed]EC, AS AMENDED FOR GENERIC HYBRID BIOSIMILAR MEDICINAL PRODUCTS APPROVED THROUGH MRP DCP Doc. Ref.: CMDh[removed]Rev. 5, July 2013 - Directive 2001 83 EC - Document - PDFSEARCH.IO

First Page	Meta Content
	CMDh RECOMMENDATION ON IMPLEMENTATION OF ARTICLE 30 DECISIONS cf. DIRECTIVE[removed]EC, AS AMENDED FOR GENERIC/HYBRID/BIOSIMILAR MEDICINAL PRODUCTS APPROVED THROUGH MRP/DCP Doc. Ref.: CMDh[removed]Rev. 5, July 2013 Add to Reading List Document Date: 2013-08-01 10:03:34 Open Document File Size: 98,01 KB Share Result on Facebook IndustryTerm medicinal product / veterinary medicinal products / medicinal products / compound/medicinal product / / Organization Commission Directorate / European Union / European Commission / / ProgrammingLanguage EC / / Technology http / / URL http / SocialTag Research Pharmaceutical sciences Health European Union Committee for Medicinal Products for Human Use Directive 2001/83/EC Summary of Product Characteristics Medicinal product Biosimilar Clinical research

CMDh RECOMMENDATION ON IMPLEMENTATION OF ARTICLE 30 DECISIONS cf. DIRECTIVE[removed]EC, AS AMENDED FOR GENERIC/HYBRID/BIOSIMILAR MEDICINAL PRODUCTS APPROVED THROUGH MRP/DCP Doc. Ref.: CMDh[removed]Rev. 5, July 2013Add to Reading List